Compile Data Set for Download or QSAR
Report error Found 93 Enz. Inhib. hit(s) with all data for entry = 11092
TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727277(US20250091992, Compound 6)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727274(US20250091992, Compound 3)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727965(US20250091992, Compound 13)
Affinity DataIC50: 20nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727968(US20250091992, Compound 24)
Affinity DataIC50: 20nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727317(US20250091992, Compound 7)
Affinity DataIC50: 20nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727214(US20250091992, Compound 2)
Affinity DataIC50: 30nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727967(US20250091992, Compound 21)
Affinity DataIC50: 30nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

Target3',5'-cyclic-AMP phosphodiesterase 4D2(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727191(US20250091992, Compound 1)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

Target3',5'-cyclic-AMP phosphodiesterase 4D2(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727373(US20250091992, Compound 11)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727191(US20250091992, Compound 1)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727275(US20250091992, Compound 4)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727350(US20250091992, Compound 9)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727971(US20250091992, Compound 31)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727974(US20250091992, Compound 35)
Affinity DataIC50: 200nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

Target3',5'-cyclic-AMP phosphodiesterase 4D2(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727277(US20250091992, Compound 6)
Affinity DataIC50: 200nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

Target3',5'-cyclic-AMP phosphodiesterase 4D2(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727214(US20250091992, Compound 2)
Affinity DataIC50: 200nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727969(US20250091992, Compound 25)
Affinity DataIC50: 300nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727351(US20250091992, Compound 10)
Affinity DataIC50: 300nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727977(US20250091992, Compound 38)
Affinity DataIC50: 400nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727330(US20250091992, Compound 8)
Affinity DataIC50: 400nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727970(US20250091992, Compound 27)
Affinity DataIC50: 400nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727975(US20250091992, Compound 36)
Affinity DataIC50: 400nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

Target3',5'-cyclic-AMP phosphodiesterase 4D2(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727317(US20250091992, Compound 7)
Affinity DataIC50: 500nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

Target3',5'-cyclic-AMP phosphodiesterase 4D2(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727965(US20250091992, Compound 13)
Affinity DataIC50: 500nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

Target3',5'-cyclic-AMP phosphodiesterase 4D2(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727970(US20250091992, Compound 27)
Affinity DataIC50: 600nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727373(US20250091992, Compound 11)
Affinity DataIC50: 600nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727277(US20250091992, Compound 6)
Affinity DataIC50: 700nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727373(US20250091992, Compound 11)
Affinity DataIC50: 800nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727976(US20250091992, Compound 37)
Affinity DataIC50: 800nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727214(US20250091992, Compound 2)
Affinity DataIC50: 900nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727973(US20250091992, Compound 34)
Affinity DataIC50: 900nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

Target3',5'-cyclic-AMP phosphodiesterase 4D2(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727967(US20250091992, Compound 21)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727965(US20250091992, Compound 13)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727191(US20250091992, Compound 1)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727970(US20250091992, Compound 27)
Affinity DataIC50: 1.20E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

Target3',5'-cyclic-AMP phosphodiesterase 4D2(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727350(US20250091992, Compound 9)
Affinity DataIC50: 1.20E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

Target3',5'-cyclic-AMP phosphodiesterase 4D2(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727274(US20250091992, Compound 3)
Affinity DataIC50: 1.30E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727317(US20250091992, Compound 7)
Affinity DataIC50: 1.30E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

Target3',5'-cyclic-AMP phosphodiesterase 4D2(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727968(US20250091992, Compound 24)
Affinity DataIC50: 1.40E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727967(US20250091992, Compound 21)
Affinity DataIC50: 1.70E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727972(US20250091992, Compound 33)
Affinity DataIC50: 2.10E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727968(US20250091992, Compound 24)
Affinity DataIC50: 2.30E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727964(US20250091992, Compound 12)
Affinity DataIC50: 2.40E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

Target3',5'-cyclic-AMP phosphodiesterase 4D2(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727983(US20250091992, Compound 44)
Affinity DataIC50: 3.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

Target3',5'-cyclic-AMP phosphodiesterase 4D2(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727984(US20250091992, Compound 45)
Affinity DataIC50: 3.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

Target3',5'-cyclic-AMP phosphodiesterase 4D2(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727979(US20250091992, Compound 40)
Affinity DataIC50: 3.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727979(US20250091992, Compound 40)
Affinity DataIC50: 3.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727979(US20250091992, Compound 40)
Affinity DataIC50: 3.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727984(US20250091992, Compound 45)
Affinity DataIC50: 3.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727984(US20250091992, Compound 45)
Affinity DataIC50: 3.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 93 total ) | Next | Last >>
Jump to: